糖尿病足合并类风湿性关节炎一例报道
A Case Report of Diabetic Foot Complicated with Rheumatoid Arthritis
DOI: 10.12677/ACM.2022.125665, PDF,   
作者: 周 甜, 杜小东:西安医学院第一附属医院内分泌科,陕西 西安;西安医学院研究生院,陕西 西安;邵小娟, 马卫国, 李 亚*:西安医学院第一附属医院内分泌科,陕西 西安
关键词: 糖尿病足类风湿性关节炎发热Diabetic Foot Rheumatoid Arthritis Fever
摘要: 本文报道2021年09月29日西安医学院第一附属医院内分泌科收治的1例62岁男性2型糖尿病足合并反复发热患者的诊疗过程。经过积极检查及诊疗临床诊断为糖尿病足合并类风湿性关节炎,且给予降温、抗感染、局部清创换药等治疗后,患足创面愈合良好。启示:临床上糖尿病足伴发热的原因主要为感染性疾病,但不局限于感染性疾病,自身免疫性疾病不易忽略,尤其在使用糖皮质激素治疗时。
Abstract: This article reported on the diagnosis and treatment of a 62-year-old male patient with type 2 dia-betic foot complicated with recurrent fever admitted to the Department of Endocrinology of the First Affiliated Hospital of Xi’an Medical University on September 29, 2021. After positive examina-tion and diagnosis and treatment, the patient was clinically diagnosed as diabetic foot complicated with rheumatoid arthritis. After cooling, anti-infection, local debridement and dressing change, the wound healed well. Revelation: Clinically, diabetic foot with fever is mainly caused by infectious diseases, but not limited to infectious diseases. Autoimmune diseases are not easy to be ignored, especially when glucocorticoids are used for treatment.
文章引用:周甜, 邵小娟, 杜小东, 马卫国, 李亚. 糖尿病足合并类风湿性关节炎一例报道[J]. 临床医学进展, 2022, 12(5): 4606-4613. https://doi.org/10.12677/ACM.2022.125665

参考文献

[1] Monteiro-Soares, M., Russell, D., Boyko, E.J., et al. (2020) Guidelines on the Classification of Diabetic Foot Ulcers (IWGDF 2019). Diabetes/Metabolism Research and Reviews, 36, e3273. [Google Scholar] [CrossRef] [PubMed]
[2] Bakker, K., Apelqvist, J., Lipsky, B.A., et al. (2016) The 2015 IWGDF Guidance Documents on Prevention and Management of Foot Problems in Diabetes: Development of an Evidence-Based Global Consensus. Diabetes/Metabolism Research and Reviews, 32, 2-6. [Google Scholar] [CrossRef] [PubMed]
[3] 李彤, 王荣英, 贺振银, 等. 不明原因发热的病因及诊断方法研究进展[J]. 中国全科医学, 2017, 20(32): 4081- 4085+4090. [Google Scholar] [CrossRef
[4] 李艳艳, 刚晓坤, 肖显超, 等. 糖尿病足合并感染的病原菌分布特点及药敏变迁的临床观察[J]. 中国糖尿病杂志, 2019, 27(1): 16-21. [Google Scholar] [CrossRef
[5] 中华医学会糖尿病学分会, 中华医学会感染病学分会, 中华医学会组织修复与再生分会. 中国糖尿病足防治指南(2019版)(III) [J]. 中华糖尿病杂志, 2019, 11(4): 238-247. [Google Scholar] [CrossRef
[6] Lipsky, B.A., Berendt, A.R., Cornia, P.B., et al. (2012) Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections. Clinical Infectious Diseases, 54, e132-e173. [Google Scholar] [CrossRef] [PubMed]
[7] 孙尚斐, 胡杰锋, 殷锦荣. 糖皮质激素联合慢作用抗风湿药治疗类风湿性关节炎的临床效果[J]. 临床医学, 2018, 38(8): 95-97. [Google Scholar] [CrossRef
[8] 于哲, 周俊, 徐艳, 等. 类风湿关节炎合并2型糖尿病临床特点分析[J]. 医学理论与实践, 2021, 34(12): 2062-2065. [Google Scholar] [CrossRef
[9] 皮慧, 张智勇, 李翊, 等. TNF-α及IL-6对类风湿关节炎并发糖代谢异常相关研究[J]. 江西医药, 2014, 49(1): 24-27. [Google Scholar] [CrossRef
[10] 李春, 王秀茹, 唐熠达, 等. 全国多中心类风湿关节炎冠心病危险因素的现况调查[J]. 北京大学学报(医学版), 2012, 44(2): 176-181. [Google Scholar] [CrossRef
[11] Pope, J.E. and Choy, E.H. (2021) C-Reactive Protein and Implications in Rheumatoid Arthritis and Associated Comorbidities. Seminars in Arthritis and Rheumatism, 51, 219-229. [Google Scholar] [CrossRef] [PubMed]
[12] Xu, J.W., Morita, I., Ikeda, K., et al. (2007) C-Reactive Protein Suppresses Insulin Signaling in Endothelial Cells: Role of Spleen Tyrosine Kinase. Molecular Endo-crinology, 21, 564-573. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, X., Bao, W., Liu, J., et al. (2013) In-flammatory Markers and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Care, 36, 166-175. [Google Scholar] [CrossRef] [PubMed]
[14] Mirjafari, H., Farragher, T.M., Verstappen, S.M., et al. (2011) Seropositivity Is Associated with Insulin Resistance in Patients with Early Inflammatory Polyarthritis: Results from the Norfolk Arthritis Register (NOAR): An Observational Study. Arthritis Research & Therapy, 13, R159. [Google Scholar] [CrossRef] [PubMed]
[15] Tentolouris, A., Thanopoulou, A., Tentolouris, N., et al. (2018) Low Preva-lence of Rheumatoid Arthritis among Patients with Pre-Existing Type 2 Diabetes Mellitus. Annals of Translational Medi-cine, 6, 399. [Google Scholar] [CrossRef] [PubMed]
[16] Semb, A.G., Rollefstad, S., Ikdahl, E., et al. (2021) Diabetes Melli-tus and Cardiovascular Risk Management in Patients with Rheumatoid Arthritis: An International Audit. RMD Open, 7, e001724. [Google Scholar] [CrossRef] [PubMed]
[17] Lu, M.C., Yan, S.T., Yin, W.Y., et al. (2014) Risk of Rheumatoid Arthritis in Patients with Type 2 Diabetes: A Nationwide Population-Based Case-Control Study. PLoS ONE, 9, e101528. [Google Scholar] [CrossRef] [PubMed]
[18] Arias De La Rosa, I., Escudero-Contreras, A., Ro-driguez-Cuenca, S., et al. (2018) Defective Glucose and Lipid Metabolism in Rheumatoid Arthritis Is Determined by Chronic Inflammation in Metabolic Tissues. Journal of Internal Medicine, 284, 61-77. [Google Scholar] [CrossRef] [PubMed]